Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Total revenue	$ 1,836,597	$ 315,902	$ 3,412,883	$ 663,927
Operating expenses
Cost of revenue	861,648	235,714	1,711,882	466,719
Selling, general and administrative expenses	2,647,524	2,042,609	4,088,110	4,373,443
Research and development expenses		83,850	4,880	157,370
Depreciation and amortization	230,338	19,705	457,298	38,792
Total operating expenses	3,739,510	2,381,879	6,262,170	5,036,324
Loss from operations	(1,902,913)	(2,065,977)	(2,849,287)	(4,372,397)
Other income (expense):
Gain (loss) from equity method joint ventures	17,846	3,788	17,950	(23,947)
Gain (loss) on disposal of fixed assets	50,000		(511,663)
Gain on lease termination			94,551
Loss on debt extinguishment	(40,491)		(40,491)
Interest expense	(369,612)	(175,192)	(550,907)	(391,781)
Foreign currency exchange loss		(265)		(400)
Total other income (expense)	(342,257)	(171,669)	(990,560)	(416,128)
Net loss before income taxes	(2,245,170)	(2,237,646)	(3,839,847)	(4,788,525)
Income taxes		2,865	1,836	2,865
Net loss	$ (2,245,170)	$ (2,240,511)	$ (3,841,683)	$ (4,791,390)
Net loss per common share:
Basic	$ (0.62)	$ (3.06)	$ (1.25)	$ (7.07)
Diluted	$ (0.62)	$ (3.06)	$ (1.25)	$ (7.07)
Weighted average number of common shares outstanding:
Basic	3,609,812	732,255	3,072,877	677,684
Diluted	3,609,812	732,255	3,072,877	677,684
Clinic Revenue [Member]
Revenue:
Total revenue	$ 1,807,921	$ 254,364	$ 3,345,120	$ 551,745
Product [Member]
Revenue:
Total revenue	$ 28,676	$ 61,538	$ 67,763	$ 112,182